Bladder cancer is arguably the most challenging GU malignancy for radiation oncologists to manage, in part because outcomes are worse than other GU malignancies, patients have a high comorbid disease burden, and providers have less experience treating the disease. Radiation oncologists are treating more and more bladder cancer patients definitively and recent studies have shown the value of hypofractionated radiation which improves convenience as well as the value of concurrent chemoRT in the setting of high-risk, recurrent non-muscle invasive disease.

There is a clear need to provide a real-world educational workshop to discuss challenging cases that are of relevance to the radiation oncologist, presenting the latest cutting edge research to explain and provide context for management decisions. We would discuss 1) Challenges in the workup and staging of bladder cancer and the use of MRI and PET/CT scan 2) Challenging definitive RT cases with respect to unfavorable bowel anatomy or very elderly/infirm patients 3) Treatment planning/dose constraints for standard and hypofractionated RT 4) Role of adaptive radiation 5) Non-muscle-invasive disease 6) Node-positive disease 7) Oligometastatic recurrent disease 8) Squamous cell carcinoma of the bladder 9) Post-cystectomy RT.